| Aurobindo Pharma up 8.4% | 24-NOV-09 |
|
| The stock jumped 8.4 per cent to Rs 852.05 after the company inaugurated its formulations manufacturing facility in its SEZ at Hyderabad. |
|
|
|
| Lifeclinic plans 100 health kiosks | 24-NOV-09 |
|
| Lifeclinic India, a part of Lifeclinic International that manufactures and distributes automated blood pressure monitors and health stations, will set up about 100 anytime self-testing health kiosks, on the lines of public telephone booths, in Andhra Pradesh. |
|
|
|
|
|
|
|
|
|
|
|
|
| Wockhardt, Sun get US okay for generic drug | 19-NOV-09 |
|
| Indian drug companies Wockhardt and Sun Pharmaceutical Industries have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug. |
|
|
|
| Model N to invest Rs 37cr | 19-NOV-09 |
|
| The company has, so far, invested $3.8 million (about Rs 17.48 crore) in India, said Zack Rinat, founder and chief operating officer. Globally, the company will invest $120 million (Rs 555 crore) during this financial year. |
|
|
|
| Wockhardt gets FDA nod for Nicardipine injections | 18-NOV-09 |
|
| Drug firm Wockhardt today said it has received the final approval from the US Food and Drug Administration (FDA) for marketing Nicardipine HCI injections in 25mg/10 ml strength, used in the treatment of hypertension. |
|
|
|
|
|
|
| India Inc discovers the power of two | 18-NOV-09 |
|
| When US-based drug major Merck bought Schering-Plough early this month, it decided to go off the beaten track. Instead of having one managing director (MD) for the merged entity, it decided to retain both: Naveen A Rao will continue to head Merck’s subsidiary MSD Pharmaceuticals in India and K G Ananthakrishnan will retain his position as MD of Schering-Plough’s subsidiary Fulford India. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Torrent Pharma ends in red despite a firm start | 16-NOV-09 |
|
| Torrent Pharma slipped into red to a low of Rs 377, down almost 7% from the day's high of Rs 405. The stock finally ended with a loss of 2.7% at Rs 382. The counter registered trades of around 36,500 shares on the BSE. |
|
|
|
Content Guide
